U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 218217
Company: AMNEAL

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
LANREOTIDE ACETATE LANREOTIDE ACETATE EQ 120MG BASE/0.5ML (EQ 120MG BASE/0.5ML) SOLUTION;SUBCUTANEOUS Prescription AB No No

Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
09/18/2026 ORIG-1 Approval STANDARD

Label is not available on this site.

LANREOTIDE ACETATE

SOLUTION;SUBCUTANEOUS; EQ 120MG BASE/0.5ML (EQ 120MG BASE/0.5ML)
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
LANREOTIDE ACETATE LANREOTIDE ACETATE EQ 120MG BASE/0.5ML (EQ 120MG BASE/0.5ML) SOLUTION;SUBCUTANEOUS Prescription No AB 218217 AMNEAL
LANREOTIDE ACETATE LANREOTIDE ACETATE EQ 120MG BASE/0.5ML (EQ 120MG BASE/0.5ML) SOLUTION;SUBCUTANEOUS Prescription No AB 217193 INVAGEN PHARMS
SOMATULINE DEPOT LANREOTIDE ACETATE EQ 120MG BASE/0.5ML (EQ 120MG BASE/0.5ML) SOLUTION;SUBCUTANEOUS Prescription Yes AB 022074 IPSEN PHARMA
Back to Top